125 related articles for article (PubMed ID: 12138652)
1. [F-18 fluorodeoxyglucose positron emission tomography in evaluation of tumors of the ENT area: personal results and review of the literature].
Kresnik E
Wien Med Wochenschr; 2002; 152(11-12):259-64. PubMed ID: 12138652
[TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
Subramaniam RM; Truong M; Peller P; Sakai O; Mercier G
AJNR Am J Neuroradiol; 2010 Apr; 31(4):598-604. PubMed ID: 19910448
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
4. [Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
Di Martino E; Hausmann R; Krombach GA; Nowak B; Tietze L; Gagel B; Zimny M; Westhofen M
Laryngorhinootologie; 2002 Dec; 81(12):866-74. PubMed ID: 12486624
[TBL] [Abstract][Full Text] [Related]
5. [Positron emission tomography (PET) in the preoperative evaluation of cervical lymph node metastasis of ORL cancer].
Lehmann W; Benchaou M; Slosman DO; Townsend D; Ryser JE; Widmann JJ; Rüfenacht D; Lacroix JS; Donath A
Schweiz Rundsch Med Prax; 1993 Dec; 82(50):1457-61. PubMed ID: 8290839
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
Rabalais AG; Walvekar R; Nuss D; McWhorter A; Wood C; Fields R; Mercante DE; Pou AM
Laryngoscope; 2009 Jun; 119(6):1120-4. PubMed ID: 19358193
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
[TBL] [Abstract][Full Text] [Related]
8. [The value of F-18 fluorodeoxyglucose in positron emission tomography diagnosis of breast carcinoma].
Langsteger W; Jörg L; Tausch C; Heinisch M; Wieser B; Rechberger E; Panholzer PJ; Sega W; Aufschnaiter M
Wien Med Wochenschr; 2002; 152(11-12):255-8. PubMed ID: 12138651
[TBL] [Abstract][Full Text] [Related]
9. Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Kim ES; Yoon DY; Moon JY; Baek S; Han YM; Seo YL; Yun EJ
Acta Radiol; 2019 Feb; 60(2):186-195. PubMed ID: 29754496
[TBL] [Abstract][Full Text] [Related]
10. [Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
Barghouth G; Allaoua M; Goerres GW
Rev Med Suisse Romande; 2000 Jun; 120(6):535-42. PubMed ID: 11014099
[No Abstract] [Full Text] [Related]
11. Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET.
Hoshikawa H; Mitani T; Nishiyama Y; Yamamoto Y; Ohkawa M; Mori N
Auris Nasus Larynx; 2009 Apr; 36(2):192-8. PubMed ID: 18606510
[TBL] [Abstract][Full Text] [Related]
12. [F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
Jörg L; Langsteger W
Wien Med Wochenschr; 2002; 152(11-12):276-9. PubMed ID: 12138655
[TBL] [Abstract][Full Text] [Related]
13. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of energy metabolism in ENT tumors--a PET study].
Reisser C; Haberkorn U; Strauss LG
HNO; 1992 Jun; 40(6):225-31. PubMed ID: 1634382
[TBL] [Abstract][Full Text] [Related]
15. [Post-therapeutic imaging strategies and follow-up in head and neck malignant tumours].
Aschenbach R; Esser D
HNO; 2010 Aug; 58(8):749-55. PubMed ID: 20640391
[TBL] [Abstract][Full Text] [Related]
16. Role of positron emission tomography (PET) in head and neck cancer.
Duet M; Hugonnet F; Faraggi M
Eur Ann Otorhinolaryngol Head Neck Dis; 2010 Mar; 127(1):40-5. PubMed ID: 20822756
[TBL] [Abstract][Full Text] [Related]
17. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
[TBL] [Abstract][Full Text] [Related]
18. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
[TBL] [Abstract][Full Text] [Related]
19. [Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor].
Schipper JH; Schrader M; Arweiler D; Müller S; Sciuk J
HNO; 1996 May; 44(5):254-7. PubMed ID: 8707630
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
de Casso C; Visvanathan V; Soni-Jaiswall A; Kane T; Nigam A
J Laryngol Otol; 2012 Mar; 126(3):295-301. PubMed ID: 22251666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
